Elastomeric Infusion Pumps Market Size, Share, Trends, Growth and Forecast 2034

Elastomeric Infusion Pumps Industry Prospective:

The global elastomeric infusion pumps market was valued at approximately USD 730.63 million in 2024 and is expected to reach around USD 1,483.58 million by 2034, growing at a compound annual growth rate (CAGR) of roughly 7.34% between 2025 and 2034.

Request Free Sample

Elastomeric Infusion Pumps Market: Overview

Elastomeric infusion pumps are portable, disposable medical devices that deliver medication to patients through controlled infusion using a pressurized elastomeric reservoir, which does not need external power or programming. These systems provide steady medication delivery over a fixed time, offering a reliable option for continuous therapy outside hospitals.

The elastomeric infusion pumps market supports hospitals seeking cost-effective solutions, home healthcare services that provide ambulatory care, specialty clinics offering outpatient treatment, and surgical centers requiring portable systems. These pumps are especially helpful for patients who need continuous medication while going about their daily activities.

The growing preference for home-based healthcare and increasing demand for ambulatory care solutions are expected to drive significant growth in the global elastomeric infusion pumps industry over the forecast period.

Key Insights:

• As per the analysis shared by our research analyst, the global elastomeric infusion pumps market is estimated to grow annually at a CAGR of around 7.34% over the forecast period (2025-2034)
• In terms of revenue, the global elastomeric infusion pumps market size was valued at around USD 730.63 million in 2024 and is projected to reach USD 1,483.58 million by 2034.
• The elastomeric infusion pumps market is projected to grow significantly due to the rising prevalence of chronic diseases requiring continuous medication.
• Based on product type, continuous-rate pumps lead the segment and are expected to continue dominating the global market.
• Based on application, chemotherapy is expected to lead the market.
• Based on end-users, hospitals are anticipated to command the largest market share.
• Based on capacity, pumps with a volume of 250-500 ml are expected to lead the market during the forecast period.
• Based on region, North America is projected to lead the global market during the forecast period.

Elastomeric Infusion Pumps Market: Growth Drivers

Rising demand for home healthcare and ambulatory care

The elastomeric infusion pumps industry is growing as healthcare systems shift toward home-based care and ambulatory treatment. These models help lower hospital stays and costs while improving patient satisfaction. Many patients prefer receiving treatment at home, which increases demand for portable and easy-to-use medical devices.

Healthcare providers support home infusion because it reduces readmissions and hospital-acquired infections while continuing effective treatment. The aging population needs long-term care for chronic illnesses, so home healthcare helps manage the rising number of patients without overloading hospitals.

Increasing prevalence of chronic diseases and cancer cases

The elastomeric infusion pumps market is growing as more people are diagnosed with chronic diseases like cancer, diabetes, and autoimmune disorders. These conditions often require continuous or frequent medication over long periods. Cancer patients on chemotherapy need long infusion schedules, and elastomeric pumps let them get treatment while continuing daily activities.

Many patients also need long-term antibiotic therapy for complex infections, and portable pumps help improve treatment adherence and reduce hospital trips. New treatment protocols that involve longer infusion times are increasing demand for reliable, portable drug delivery systems that ensure accurate dosing.

Elastomeric Infusion Pumps Market: Restraints

Limited medication compatibility and dosing flexibility

Despite their growing use, the elastomeric infusion pump market has some limitations in terms of medication compatibility and dosing flexibility compared to electronic infusion systems. These limitations can restrict their use for specific therapies. Some medications cannot be used with elastomeric pumps due to stability concerns, chemical reactions with materials, or storage needs that the device cannot meet.

Many of these pumps have fixed flow rates, which limit their use for drugs that need dose adjustments or complex infusion plans requiring real-time changes. Healthcare providers may avoid using elastomeric pumps for critical medications where precise control and monitoring are essential for patient safety.

Elastomeric Infusion Pumps Market: Opportunities

Expansion in emerging healthcare markets

The elastomeric infusion pumps market presents strong opportunities in emerging healthcare markets, where infrastructure is expanding and healthcare spending is increasing. These regions are searching for cost-effective and reliable medical device solutions.

Developing countries need affordable alternatives to the costly electronic infusion pumps, and elastomeric pumps are appealing to budget-conscious facilities. These pumps are simple, dependable, and suitable for resource-limited areas where technical support and maintenance may be lacking.

Government healthcare programs in emerging markets are increasing access to essential care, which is boosting the use of portable and easy-to-use medical devices.

Elastomeric Infusion Pumps Market: Challenges

Competition from advanced electronic infusion systems

The elastomeric infusion pumps market is facing competition from electronic infusion systems that offer advanced features, better monitoring, and more accurate dosing.

Modern electronic pumps provide real-time monitoring, adjustable dosing, and system integration, which appeals to hospitals seeking complete infusion management solutions. Rapid progress in smart infusion technologies, including connectivity and data analytics, is challenging traditional elastomeric pump manufacturers.

In developed markets, healthcare providers may prefer electronic systems despite higher costs because of safety benefits and the detailed records they provide. As electronic pumps become cheaper and reach more markets, it becomes crucial to show the value and cost benefits of elastomeric pumps clearly.

Request Free Sample

Elastomeric Infusion Pumps Market: Report Scope

Elastomeric Infusion Pumps Market: Segmentation

The global elastomeric infusion pumps market is segmented into product type, application, end-user, capacity, and region.

Based on product type, the market is segregated into continuous rate pumps, variable rate pumps, and multi-rate pumps. Continuous rate pumps lead the market due to their simplicity, reliability for standard infusion protocols, and widespread acceptance for common therapeutic applications requiring steady medication delivery.

Based on application, the elastomeric infusion pumps industry is classified into chemotherapy, pain management, antibiotics, and post-operative care. Chemotherapy holds the largest market share due to the growing cancer patient population, extended treatment protocols requiring prolonged infusion times, and patient preference for ambulatory chemotherapy administration.

Based on the end user, the elastomeric infusion pumps market is divided into hospitals, ambulatory surgical centers, home healthcare, and specialty clinics. Hospitals are expected to lead the market during the forecast period due to their central role in patient care, high patient volumes requiring infusion therapy, and established procurement processes for medical devices.

Based on capacity, the market is segmented into 100-250ml, 250-500ml, and above 500ml. The 250-500ml segment leads the market share due to its versatility for most common infusion protocols, optimal balance between portability and medication volume, and suitability for standard treatment durations.

Elastomeric Infusion Pumps Market: Regional Analysis

North America to lead the market

North America leads the global elastomeric infusion pumps market due to its strong healthcare infrastructure, widespread home healthcare services, and favorable reimbursement for ambulatory care. The region also has a high adoption of new technologies by healthcare providers. It accounts for approximately 40% of the global market, with the United States being the largest consumer of elastomeric infusion pump systems.

Many healthcare facilities have established ambulatory care programs, creating a steady demand for portable and reliable devices that support patient mobility and improve quality of life. The region’s mature home healthcare industry and network of specialized infusion service providers create a supportive environment for the adoption of pumps.

Strong collaborations between device manufacturers, healthcare providers, and insurers have made ambulatory infusion therapies widely accepted and reimbursable. Government healthcare policies that promote cost-effective and patient-centered care further support market growth and the adoption of technology.

Europe is expected to demonstrate steady expansion.

Europe is growing in the elastomeric infusion pumps industry as healthcare systems across EU countries adopt ambulatory care models and cost-saving strategies that support the use of medical devices.

The region’s focus on sustainability and cost-effectiveness fits well with the economic advantages of elastomeric pumps for routine medication delivery. Hospitals are using these devices to shorten hospital stays while still maintaining high patient care standards. An aging population and rising chronic diseases in Europe are increasing the need for home-based infusion services.

European regulatory frameworks encourage the development and approval of medical devices that are both safe and effective. These regulations help maintain high standards of patient safety and device quality. Growing budgets for community care and outpatient services are helping portable infusion technologies become part of mainstream healthcare in the region.

Recent Market Developments:

• In May 2025, B. Braun Medical introduced a new line of smart elastomeric infusion pumps featuring integrated flow monitoring capabilities and patient safety features designed to enhance ambulatory care delivery.
• In March 2025, Baxter International announced the expansion of its elastomeric pump manufacturing facilities to meet the growing global demand for home healthcare infusion solutions.

Elastomeric Infusion Pumps Market: Competitive Analysis

The global elastomeric infusion pumps market is led by players like:

• B. Braun Melsungen AG
• Baxter International Inc.
• Fresenius Kabi AG
• Smiths Medical
• Nipro Corporation
• Leventon S.A.U.
• Avanos Medical Inc.
• Teleflex Incorporated
• Halyard Health Inc.
• Epic Medical Concepts and Innovations Inc.
• Ambu A/S
• Vygon SA
• Medical Components Inc.
• AccuFlo Inc.
• Woo Young Medical Co. Ltd.
• Shanghai Kindly Enterprise Development Group Co. Ltd.
• Promecon GmbH
• Silmag SA
• Technimed Ltd.
• RyMed Technologies LLC.

The global elastomeric infusion pumps market is segmented as follows:

By Product Type

• Continuous Rate Pumps
• Variable Rate Pumps
• Multi-Rate Pumps

By Application

• Chemotherapy
• Pain Management
• Antibiotics
• Post-Operative Care

By End User

• Hospitals
• Ambulatory Surgical Centers
• Home Healthcare
• Specialty Clinics

By Capacity

• 100-250ml
• 250-500ml
• Above 500ml

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa